Dose-Ranging Study in Patients With Chronic Obstructive Pulmonary Disease (COPD)

NCT00098228 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

686

Enrollment

INDUSTRY

Sponsor class

Conditions

COPD

Interventions

DRUG: QAB149

Sponsor

Novartis Pharmaceuticals